These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
618 related articles for article (PubMed ID: 26380104)
1. Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria. Bollée G; Cochat P; Daudon M Can J Kidney Health Dis; 2015; 2():31. PubMed ID: 26380104 [TBL] [Abstract][Full Text] [Related]
2. Crystalline Nephropathy due to APRT Deficiency: A Preventable Cause of Renal and Renal Allograft Failure. Rajput P; Virani ZA; Shah BV Indian J Nephrol; 2020; 30(4):290-292. PubMed ID: 33273797 [TBL] [Abstract][Full Text] [Related]
3. Rare crystalline nephropathy leading to acute graft dysfunction: a case report. Bagai S; Khullar D; Bansal B BMC Nephrol; 2019 Nov; 20(1):428. PubMed ID: 31752739 [TBL] [Abstract][Full Text] [Related]
7. [2,8-dihydroxyadenine urolithiasis: case report and literature review]. Arancio M; Ranzoni S; Delsignore A; Landi G; Maffei N; Marcato M; Mina A; Martinengo C Urologia; 2011; 78(4):305-9. PubMed ID: 21553389 [TBL] [Abstract][Full Text] [Related]
9. Primary and secondary hyperoxaluria: Understanding the enigma. Bhasin B; Ürekli HM; Atta MG World J Nephrol; 2015 May; 4(2):235-44. PubMed ID: 25949937 [TBL] [Abstract][Full Text] [Related]
10. End Points for Clinical Trials in Primary Hyperoxaluria. Milliner DS; McGregor TL; Thompson A; Dehmel B; Knight J; Rosskamp R; Blank M; Yang S; Fargue S; Rumsby G; Groothoff J; Allain M; West M; Hollander K; Lowther WT; Lieske JC Clin J Am Soc Nephrol; 2020 Jul; 15(7):1056-1065. PubMed ID: 32165440 [TBL] [Abstract][Full Text] [Related]
11. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure. Raju DL; Cantarovich M; Brisson ML; Tchervenkov J; Lipman ML Am J Kidney Dis; 2008 Jan; 51(1):e1-5. PubMed ID: 18155525 [TBL] [Abstract][Full Text] [Related]
12. Management of urinary stones: state of the art and future perspectives by experts in stone disease. Papatsoris A; Alba AB; Galán Llopis JA; Musafer MA; Alameedee M; Ather H; Caballero-Romeu JP; Costa-Bauzá A; Dellis A; El Howairis M; Gambaro G; Geavlete B; Halinski A; Hess B; Jaffry S; Kok D; Kouicem H; Llanes L; Lopez Martinez JM; Popov E; Rodgers A; Soria F; Stamatelou K; Trinchieri A; Tuerk C Arch Ital Urol Androl; 2024 Jun; 96(2):12703. PubMed ID: 38934520 [TBL] [Abstract][Full Text] [Related]
13. 2,8-Dihydroxyadenine Nephropathy Identified as Cause of End-Stage Renal Disease After Renal Transplant. George SA; Al-Rushaidan S; Francis I; Soonowala D; Nampoory MRN Exp Clin Transplant; 2017 Oct; 15(5):574-577. PubMed ID: 27447713 [TBL] [Abstract][Full Text] [Related]
14. An update on primary hyperoxaluria. Hoppe B Nat Rev Nephrol; 2012 Jun; 8(8):467-75. PubMed ID: 22688746 [TBL] [Abstract][Full Text] [Related]
15. Recurrence of 2,8-dihydroxyadenine Crystalline Nephropathy in a Kidney Transplant Recipient: A Case Report and Literature Review. Cheng Y; Guo L; Wang M; Chen J; Wang R Intern Med; 2021 Aug; 60(16):2651-2657. PubMed ID: 33678741 [TBL] [Abstract][Full Text] [Related]
16. A Rare Case of APRT Deficiency with End-stage Renal Failure and Successful Renal Transplant. Sharma M; Gowrishankar S; Jeloka TK Indian J Nephrol; 2021; 31(1):57-60. PubMed ID: 33994690 [TBL] [Abstract][Full Text] [Related]
17. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
18. Primary Hyperoxaluria Type 1 with Thrombophilia in Pregnancy: A Case Report. Hasan A; Maynard S; Santoriello D; Schairer H Case Rep Nephrol Dial; 2018; 8(3):223-229. PubMed ID: 30397603 [TBL] [Abstract][Full Text] [Related]